Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2005-09-20
2005-09-20
Desai, Rita (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S428000, C546S236000, C548S570000
Reexamination Certificate
active
06946475
ABSTRACT:
The present invention is directed to compounds useful as cancer cell inhibitors, compositions containing such compounds and methods for inhibiting proliferation of electrically non-excitable cells.
REFERENCES:
patent: 3732247 (1973-05-01), Helsley et al.
patent: 4908365 (1990-03-01), Buzas et al.
patent: 4957927 (1990-09-01), Ferrand et al.
patent: 0 805 147 (1997-11-01), None
patent: WO 92/05172 (1992-04-01), None
patent: WO 97/10212 (1997-03-01), None
Benzaquen, Laura R., et al. “Clotrimazole inhibits cell proliferation in vitro and in vivo”, Nature Medicine, vol. 1., No. 6, Jun. 1995, pp. 524-540.
Cohen, R.B., et al. “Pilot study of pharmacologic inhibition of calcium entry blockers in the treatment of advanced breast and prostate cancer”, Proc. Annu. Meet. Am. Soc. Clin. Oncol., vol. 16, 1997, p. 538a.
Densmore, John J., et al., “A voltage-gated calcium channel is linked to the antigen receptor in Jurkat T lymphocytes”, Febs Letters, vol. 312, No. 2,3, Nov. 1992, p. 161-164.
Densmore, John J., et al. “A voltage-operable current is involved in Ca2+ entry in human lymphocytes whereas ICRAC has no apparent role”, Am. J. Physiol, vol. 271 (1996).
Haverstick, Doris M., “Calmodulin regulation of Ca2+ entry in Jurkat T cells”, Cell Calcium, 23(6):361-367, (1998).
Wikstrom, Peter, et al. “Additional peptidyl diazomethyl ketones, including biotinyl derivatives, which affinity-label calpain and related cysteinyl proteinases”, J. Enzyme Inhibition, 1993 vol. 6, pp. 259-269.
Gray Lloyd S.
Haverstick Doris
Heady Tiffany N.
Macdonald Timothy L.
Breen John P.
Covington Raymond
Desai Rita
University of Virginia Patent Foundation
LandOfFree
Anticancer calcium channel blockers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anticancer calcium channel blockers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anticancer calcium channel blockers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3385789